Alecensa.com

Visit alecensa.com
  • 1K

    Daily Visitors

  • 8 months ago

    Last scanned

  • 11 years

    Domain Age

  • No data

    Global Rank

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

ALECENSA® (alectinib) and Information for Patients

Find information for patients about treatment with ALECENSA® (alectinib). See full safety for more information.

Alecensa.com thumbnail
Alecensa.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Amazon Technologies Inc., which reserves the following IP addresses for alecensa.com: 52.8.240.212, 54.153.55.226. Moreover, DNS used with this website include a1-178.akam.net, a18-66.akam.net, a4-67.akam.net, a6-65.akam.net, a7-66.akam.net, a9-66.akam.net. Subnet identifier ranges from 52.0.0.0 to 52.79.255.255. Classless Inter-Domain Routing (CIDR) is 52.0.0.0/10, 52.64.0.0/12. ARIN net type is Direct Allocation.

  • 1K

    Daily Visitors

  • 8 months ago

    Last scanned

  • 11 years

    Domain Age

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

  • Created

    2012-12-26

  • Expires

    2023-12-26

  • Owner

    REDACTED FOR PRIVACY

  • Registar

    1API GmbH

  • Owner Emails

    domain.master@brights.jp

Domain & Keywords

The registrar of alecensa.com is 1API GmbH and the name expires on 2023-12-26. According to open source data, you can reach the owner at domain.master@brights.jp but please make sure you have a good reason for unsolicited messages. Their country of residence is China.

  • genentech
  • genentech biooncology
  • biooncology
  • ALK inhibitor
  • alectinib
  • anaplastic lymphoma kinase
  • alecensa
  • alk-positive nsclc treatment
  • alk-positive non-small cell lung cancer medication
  • alectinib fda

Websites similar to alecensa.com